Alejandra Estepa

PhD in Biotechnology | Project Manager | The opinions expressed are my own and are not endorsed by Quibim

[Quibim @QuibimBiomarker]

📍 To end this week full of events, we are at #ESOI2024, in Valencia (our home city!) to discuss the latest advancements on #oncologycare.

Swing by to say hi to our team and get a glimpse of the latest advancements in medical imaging applied to #cancer care.

[Quibim @QuibimBiomarker]

We are thrilled to announce our participation at the 65th American Society of Hematology (ASH) Annual Meeting, currently being held in San Diego.

Today we are proud to present our poster "CART-AI-Radiomics: Survival and Neurotoxicity Prediction in B-Cell Lymphoma Patients Treated with CAR-T Cells through an Imaging Features-Based Model" in which we propose a model combining imaging features (MTVtotal, SUVmax and TLGtotal) with clinical variables measured before lymphodepletion (ICANS, C-reactive protein, LDH, lymphocytes count) that successfully predicts overall survival (p = 0.019) and progression-free survival (p = 0.007). A similar model also predicted the development of neurotoxicity with an AUC of 0.971, a sensitivity of 0.813, a specificity of 0.846 and an accuracy of 0.828.

You can read the full article here: https://t.co/uVyV5V9L26
#ASH2023 #DLBCL #PMBCL #CART #Radiomics #ImagingFeatures

[Quibim @QuibimBiomarker]

As we bid farewell to #ESMO2023 Congress, we are brimming with inspiration and insight. These days gathered minds from around the globe, fostering collaborations that will shape the future of #oncology.
Keep the conversation, collaboration, and innovation going. Until next time, stay curious, passionate, and committed to making a difference.
#OncologyInnovation #MedicalResearch #HealthcareAdvancements #MedicalEducation

[Ana González Manteiga, PhD @anagonzaman]

Hi! I'm looking for industry and postdoc positions. High expertise in neuronal cultures, stereotactic surgeries, viral tracing, mouse behavior, brain histology and imaging. Strongly interested on neural plasticity for brain disease. Please share! 🧠🔬
#neurojob
@PostdocVoice

[Quibim @QuibimBiomarker]

Save the date for our upcoming webinar: "Cancer Immunotherapy: Exploring Imaging for Immune Response Prediction" with @Xtalks.

Discover the future of immunotherapy, predictive biomarkers, CD8 T cells, and AI in response assessments.

🗓️ Date: Sep 27, 2023 🕑 Time: 2pm EDT

For more details and registration: https://t.co/TITqvKmV79

[Quibim @QuibimBiomarker]

Join the @chaimeleon_eu Project Open Challenges: A unique opportunity for scientists globally to advance cancer research using #AI. Prizes totaling up to €100,000 will be distributed among the winners.

Are you interested? Click the link! https://t.co/oTnjFavIZc

[Alejandra Estepa @aestepaf]

Really interesting article sharing the benefits of radiomics in predicting the outcome of lymphoma patients using diagnostic baseline PET

[Benlazar S M A @smbenlazar]

A man’s best friend is his PET.
>>> Baseline PET radiomics outperforms the IPI risk score for prediction of outcome in diffuse large B-cell lymphoma #DLBCL https://t.co/4lhK7AW1Y8 #lymsm

[Quibim @QuibimBiomarker]

Transforming #liverdisease #diagnosis: using Convolutional Neural Networks (CNN) for automatic liver #segmentation and #quantification in MRI imaging. Read more in our blog: https://t.co/ksMJKYxFZU Stay tuned for more advancements in health tech! #AI #healthtech #precisionmedicine

[Quibim @QuibimBiomarker]

Are you attending the #ASCO2023 meeting? We're presenting our groundbreaking work focusing on identifying an imaging signature that predicts progression-free survival (PFS) in locally advanced head and neck squamous cell carcinoma (LAHNSCC). We continue exploring the power of #imagingbiomarkers in enhancing personalized treatment strategies for future clinical trials.
#Precisionmedicine #CancerResearch #Oncology
https://t.co/hjlOV5VPkT

[Quibim @QuibimBiomarker]

Yesterday, our Project Manager, Alejandra Estepa, had the honor of presenting Quibim's state-of-the-art advancements and pioneering innovations in the medical imaging sector to students enrolled in the Master's Degree in Access to the Health Industry.

In partnership with @farmaleaders our goal at Quibim is to empower the healthcare leaders of tomorrow. Through sharing our knowledge and experience, we aim to inspire and guide these students on their professional paths.

[Quibim @QuibimBiomarker]

Quibim and @ImaginAbInc have teamed up to transform immune status diagnosis and #immunotherapy prediction. This partnership strives to boost accuracy and efficiency in response, ultimately improving patient outcomes.

Read everything about it! https://t.co/GGxBYiuXk5

#precisionmedicine #AI

[Radio Val @RadioVal_AI]

🎉RadioVal is welcoming external stakeholders!
We are an #EUfunded project that aims to validate an #ArtificialIntelligence solution for #breastcancer treatment planning.
Learn more about us via our website and fill in the form✍️to become our stakeholder:
https://t.co/QqeuvbCvtu

[Alejandra Estepa @aestepaf]

Really happy to have the opportunity to share the discussion with the participants to the @EatrisEric Summer School. #PrecisionMedicine is already a reality in the clinic, but taking advantage of the #AItools we can increase the benefits of the #patients.

[Quibim @QuibimBiomarker]

We would like to highlight the fact that today Alejandra Estepa, Project Manager at Quibim, attended the Summer School in Personalised Medicine Congress organized by @EatrisEric in @INFARMED_IP in Lisbon. Her presentation highlighted the potential of these tools in personalized #medicine research focusing on medical imaging and the challenges that need to be addressed in their implementation.

#AI #PrecisionMedicine

[CHAIMELEON @chaimeleon_eu]

📢 We seek collaborators providing retrospective datasets! In return, you will receive compensation, access to results, decision support tools, and authorship in publications.
📅Deadline: April 21
Learn more: https://t.co/PcCvadXzT4

#AIforCancer #ClinicalCollaboration #H2020

[Alejandra Estepa @aestepaf]

Really proud to form part of the #Quibim team!

[Quibim @QuibimBiomarker]

Are you ready to revolutionize #prostatecancer diagnosis and treatment planning? Our very own QP-Prostate, combines automated segmentation, machine learning algorithms and #AI to pave the way for more accurate and efficient segmentation in clinical practice.

[Quibim @QuibimBiomarker]

Because every day should be #WomeninScienceDay let’s keep honoring all women who work in Quibim who have backgrounds in science since they are the ideal role model for younger generations.

Would you like to join our team? Visit our careers page https://t.co/in8AXKniRz

[Quibim @QuibimBiomarker]

Quibim joins #EUCAIM, a new @EU_Commission project to create a federated infrastructure for #imagingdata to fight against cancer connecting hospitals and repositories to improve early detection and treatment options. https://t.co/1DSjPWplb5

[Quibim @QuibimBiomarker]

Quibim keeps growing! We are looking for #newtalents in several roles. If you would be a good fit, please send us your CV or join the Talent Pool. #BeaQuibimer! https://t.co/in8AXKniRz

[Alejandra Estepa @aestepaf]

Santa brought me this present for Christmas!! 🎁

Check here my last work!

[Mammary Cell News @MammaryCell]

#NanoparticleCommunication seems pretty high tech — but @aestepaf and co-authors took it further, targeting #TNBC tumors with a strategy that involves nanoparticle-cell-nanoparticle communication through #stigmergy.

Read more 📕: https://t.co/icCeeB5hui